Heme-containing proteins have recently attracted increasing attentionf or their ability to promote synthetically valuable transformationsn ot found in nature.F ollowing the recent discovery that engineered variants of myoglobin can catalyzet he direct conversion of organic azides into aldehydes, we investigated the azide oxidative deamination reactivity of av ariety of hemoproteins featuring different heme coordination environments.O ur studies show that althoughs everal heme-containing enzymes possess basal activity in this reaction, an engineered variant of the bacterial cytochrome P450 CYP102A1 constitutes ap articularly efficient biocatalyst for promoting this transformation, and it exhibits ab road substrate scope along with high catalytic activity (up to 11 300 turnovers), excellent chemoselectivity,a nd enhanced reactivity toward secondary alkyl azides to yield ketones. Mechanistic studies and Michaelis-Menten analyses provided insighti nto the mechanism of the reactiona nd the impact of active-site mutations on the catalytic properties of the P450. Altogether,t hese studies demonstrate that engineered P450 variantsr epresent promisingb iocatalysts for the synthesis of aryl aldehydes and ketones through the oxidative deamination of alkyl azides under mild reactionconditions.
CytochromeP 450s constitute as uperfamily of iron-dependent, heme-containing oxygenases that play an important role in drug metabolism,b iodegradation, and the biosynthesis of secondary metabolites.
[1] These enzymes have received significant attentionf or their ability to hydroxylate aliphatic and aromatic CÀHb onds, ac hallenging reaction to achieve by chemical means.
[2] Furthermore, P450s are known to promote av ariety of other oxidative transformations, including heteroatom dealkylation, carbon-carbon bond cleavage, rearrangement reactions, and Baeyer-Villiger reactions.
[3] More recently,t he scope of cytochrome P450s was extended to an umber of important, "non-native" reactions useful for the construction of carboncarbon, [4] carbon-nitrogen, [5] and nitrogen-sulfur [6] bonds. Our group recentlyr eported that the heme-containing protein myoglobin (Mb) constitutes ap romising scaffold for promoting avariety of synthetically useful transformations mediated by metal-carbenoid and -nitrenoid species. [7] In particular, previous work showedt hat engineered variants of this hemoprotein can catalyze the oxidatived eamination of organic azides to generatea ldehydes. [8] In comparison to classical methodsi nvolving alcoholo xidationw ith toxic chromiumbased reagents, this transformation provides ac onvenient approach to the synthesis of aldehydes starting from an on-oxygenatedf unctional group and by using readily accessible alkyl azides. Furthermore, synthetic catalysts [e.g.,M oO 2 (S 2 CNEt 2 ) 2 ] currently available to promote this reaction suffer from poor catalytic efficiency (20-200 turnovers) and require harsh reaction conditions (reflux in toluene/water mixture). [9] In the interest of comparing and contrasting the reactivities of hemoproteins featuring different heme coordination environments in the context of non-native reactions, we investigateda nd report herein the azide oxidative deaminationr eactivityo f apanel of different heme-containingenzymes, including acatalase, ap eroxidase, andw ildtype and engineered variants of ab acterial cytochrome P450. These studies led to the identification of an engineered variant of CYP102A1 as as uperior biocatalystf or the conversion of ab road range of aryl-substituted alkyl azides into the corresponding aldehydes and ketones. In addition, insighti nto the mechanism and catalytic properties of this enzymew as gained through ac ombination of kinetic studies and isotopiclabeling experiments.
To investigate the scopeo fh emoprotein-catalyzed azide-toaldehyde oxidation, we initially selected ap anel of different heme-containing enzymes consistingo fb ovine catalase (Cat), horseradish peroxidase (HRP), and the bacterial cytochrome CYP102A1 [10] (also known as P450 BM3 ). [11] Theh eme coordination environments among these enzymes are significantly differenta nd, additionally,a re different to that of the previously investigated Mb. In Cat and CYP102A1, the amino acidl igands involved in coordinating the heme iron are tyrosine and cysteine residues, respectively, [12] as opposed to histidine in Mb. [13] The heme group in HRPi sa lso bound throughah istidine residue, [14] but as trongH -bonding interaction between this proximal His and aneighboring aspartic acid residue confers considerable anionic character to the former,astructural feature that is not presenti nM b. Finally,h emoglobin (Hb) was also considered to evaluate the effect of the tetrameric structure on the targetr eactivity as opposedt ot he monomeric structure of Mb.
As am odel reaction, the conversion of benzyla zide (1)i nto benzaldehyde( 2a)u nder anaerobic conditions in phosphate buffer (KPi, pH 7.0) andi nt he presence of sodium dithionite (Na 2 S 2 O 4 )a sareductant ( Figure 1a )w as used to assess the relative efficiency of these hemoproteins in promoting azide oxidative deamination. Under these conditions, Cat, HRP,a nd Hb showed only low to moderate reactivity,w hich supported ap-proximately 5, 63, and1 95 turnovers (TONs), respectively (Figure 1b, c) . These TON valuesa re lower or comparable to that achieved with free hemin under similar reaction conditions ( % 100 TONs). [8] The poor performance of Hb was somewhat unexpectedi nl ight of the high reactivity of the structurally related Mb in this transformation( 1650 TONs) [8] and it could stem from unfavorable allosteric effects in the case of the oligomeric protein. In contrast, wildtype CYP102A1 showedc onsiderably higher azide oxidation activity,w hichs upported 1400 catalytic turnovers for the formation of desired product 2a and provided ap roduct conversion ratio of 18 % ( Figure 1b ,c)T he reaction also produced small amounts of benzylamine (2b,0 .5 %) and N-benzylbenzylimine (2c, < 3%), as observed in the Mbcatalyzed reaction. [8] Formation of byproduct 2b was ascribed to an unproductive pathway resulting from decomposition of the azide followed by reduction and protonation of the resulting nitrene-heme intermediate, whereas 2c originates from condensation of 2b with the aldehyde product. [8] Importantly, these initial results clearly evidenced the impact of the heme coordination environment on the reactivity of the different hemoproteins towardorganic azides, therebye xpanding previous findings from our group.
[7e] Indeed,w hereas HRP was previously found to promotet he intramolecular CÀHa minationo fa rylsulfonyl azides with comparable or higher activity than P450s or Mb, [5a, b, 7e] this enzymes howed significantly reduced activity toward azide-to-aldehyde conversion compared to the latter hemoproteins. Conversely,t he data in Figure 1b ,c suggested that, despite the inherent differences between their active sites, the thiolate-bound heme in P450 is equally efficient as the histidinyl-bound heme cofactor in Mb in promoting the oxidatived eaminationo fa lkyl azide 1 (1400 TONs vs. 1650 TONs for wildtype Mb [8] ). Given the promising activity of wildtype CYP102A1, we next extended our investigationst ot wo engineeredv ariantso ft his enzyme, namely,C YP102A1(F87A) and FL#62. The former variant was chosen because of the well-documented ability of the F87A mutation to expand the substrate profile of CYP102A1 toward non-native substrates in the context of monooxygenation reactions. [11, 15] In addition to possessing ab road substrate profile, [16] the FL#62 variant,w hichc arries 6a ctive-site mutations and 10 additional mutations within its heme domain, was chosen because of its high reactivityi nt he context of the CÀH amination of azide-based reagents. [5a, b] As shown by the data summarized in Figure1,C YP102A1(F87A) showedo nly slightly improved TON values for the conversiono fb enzyl azide (1) into benzaldehyde (2a)r elative to the wildtype P450 (1600 vs. 1400 turnovers). In contrast, FL#62 was found to catalyzet his transformation with considerably highere fficiency (Figure 1b,c) , supporting 9700 catalytic turnovers and providing nearly quantitative product conversion (92 %) at ac atalyst loading of merely 0.001 mol %. At lower catalyst loadings (0.0005 mol %), aT ON value as high as 11 300 was measured for this enzyme. Notably,t he FL#62 reactionw as found to proceed also with excellent chemoselectivity,w hich led to the clean formation of 2a withoutp roducing detectablea mounts of byproduct 2b or 2c.A ltogether,t hese properties make FL#62 not only ac onsiderably more efficient catalytic system for azide-to-aldehyde conversion than synthetic Mo-based catalysts (50-99 %c onversions by using 10 mol %a t1 00 8Ci n water/toluene mixture) [9a] but also as uperior biocatalystt ot he best-engineered Mb variant [Mb(H64V,V68A)] identified in the course of our previouss tudies. [8] Further characterization studies revealed an oticeable effect of pH on FL#62 azide oxidatived eamination activity,a nd maximal TON values were achieved around neutralp H ( Figure 1e ). As imilarp Hd ependence was observed fort he Mb-catalyzed reaction. [8] From time-course experiments, the FL#62-catalyzed conversion of 1 into 2b was determined to proceed with ar ate of approximately 14 turnovers per minute over the first 10 min (Figure 1d ). This rate is lower than that observedf or the Mb-based catalysts (250 min À1 ), [8] but the FL#62-catalyzed reactionp roceeded with higher selectivity (i.e.,n o2b/2c formation) in addition to the higherT ON value. The initial product formation rates for FL#62 and the other hemoproteins investigated also correlatedw ell with the TON values observed in the corresponding reactions (Figure 1b,d) . Next, the substrate scope of the FL#62biocatalyst was investigated by using aw ide panel of different organic azides. As shown in Ta ble 1, the majorityoft hesec ompounds were readily oxidized to the corresponding aldehydes in good to excellent yields (49-99 %), as determined by GC. In these reactions, P450 was determined to support from 4650 to 9660 TONs. In addition, the reaction proceeded with high selectivity (> 90-95 %), in particularf or the alkyl azides most efficiently processed by the enzyme. The viable substrates included variously mono-a nd disubstituted benzyl azide derivatives (i.e., 3a, 4a, 6a, 8a, 10 a,a nd 11 a), (hetero)aryl-substituted primary alkyl azides (i.e., 17 a and 18 a), and secondary alkyl azides (i.e., 15 a and 16 a), which supported the broad substrate scope of the FL#62 catalyst.M odest (20-30 %) to low (< 20 %) product conversions were observed instead with benzyla zide derivatives that carried one or two substituents at the ortho position(s) (i.e., 7b, 9b,a nd 13 b). These resultss uggested an egative effect on the enzymatic transformation of increased steric hindrance in proximity to the azido group. Whereas the conversion yields of these P450-catalyzed reactions were consistently higher than those achieved with engineered myoglobins, [8] particularly striking is the considerably higher efficiency of the P450 catalysti nt he synthesis of ketones 15 b and 16 b from secondary alkyl azides 15 a and 16 a,r espectively.I ndeed, whereas this reactionp roceeded inefficiently in the presence of the Mb catalyst (280-400TONs, < 2% conversion), [8] it was effectively catalyzed by the engineered P450 (4650-7470 TONs), which resulted in much improved product conversions (49-76 %).
To further evaluatet he synthetic utility of FL#62 in the context of this reaction, al argers cale reaction with benzyla zide (1;5 0mg, 0.38 mmol) wasp erformed in the presence of 0.05 mol %FL#62inphosphate buffer (pH 7.0) at room temperature. After simple extraction and purification steps, the desired benzaldehyde product 2a was isolated in 87 %y ield (35 mg, 0.33 mmol), which thus supported the scalabilityo f this biocatalytic transformation.
With respect to the mechanism,w ep reviously proposed that this reaction involves heme-catalyzed decomposition of the heme-bound alkyl azide to give an imido-iron(IV) intermediate. The latter could then undergo tautomerization to an imine-iron(II) complex, followed by hydrolysis of the imine( in either free or heme-bound form) to yield the aldehyde product (Figure 2 ). Experimental evidence in support of the imine tautomerization step included the observation of as ignificant kinetic isotope effect (KIE) upon H!Ds ubstitutiona tt he level of the a carbon atom in the azide substrate. [8] Interestingly, ar elated imine intermediate was recently invoked in the azideto-nitrilec onversion catalyzed by non-heme iron-dependent dioxygenases. [17] Furthermore, 18 O-labeling experimentsi ndicated that the oxygen atom in the aldehyde product derives from ah ydrolytic process. [8] In light of the higher catalytic activity (i.e.,T ON) and slower rate of the P450-catalyzed reaction versus the Mb-catalyzed one, we thus wonderedw hether these biocatalytic transformations shared an analogousm echanism or not. To this end, we measured the KIE for the FL#62-catalyzed oxidative deaminationo fb enzyl azide (1)f rom competition experimentsi nt he presenceo fa ne quimolar concentration of the deuterated analogue,[ D 2 ]-1.G C-MS analysiso f this reaction (Figure S3 a, Supporting Information) yielded aK IE value (k H /k D )o f1 .9 AE 0.2 at 22 8C, which is comparable to that observed in the presence of Mb(H64V,V68A) as the catalyst (k H / k D = 1.7 AE 0.3). [8] In addition, the FL#62-catalyzed conversion of benzyla zide (1)i nt he presence of 18 O-labeled water resulted in the formation of 18 O-labeled aldehyde product 2a ( 18 O) (Figure S3 b) , as observed for the Mb-catalyzed reaction. Altogether,t hese resultsh int at important mechanistics imilarities between the two systems, althoughd ifferences between them are also apparent. Indeed, the low formationo ft he amine byproduct in the FL#62 reactions across all the tested azide sub- www.chemcatchem.org strates suggests that the unproductive pathway leading to this reduction is more disfavored in the case of the P450 system. In addition, the significantly higher (10-to 15-fold) conversions and TON values measured for the FL#62-catalyzed formation of 15 b and 16 b versus 14 b (Table 1) suggest that the P450 catalyst is significantly more sensitive to an increasei nt he acidity of the a protons than the Mb catalyst (three-to fourfold higher TON for 15 b and 16 b,r espectively,r elative to the TON for 14 b). [8] Kinetic experiments with wildtype CYP102A1, CYP102A1(F87A), and FL#62 were performed to gain further insight into the catalytic properties of these enzymes. In the reaction with model substrate 1,a ll of these P450s were found to follow Michaelis-Menten kinetics ( Figure 3) . Similark inetic parameters (Michaelis constant, K M ;t urnover number, k cat )w ere determined for the parent enzyme and its single mutant variant, CYP102A1(F87A), which is consistentw ith their similar performance in terms of TON and product conversion (Table 1) . Conversely,t he superior catalytic performance of FL#62 is reflected by the eight fold higherc atalytic efficiency (k cat /K M = 4.6 10 2 m s À1 )c ompared to that of the parente nzyme and F87A variant, which derives as ar esult of at wofold lower K M value and af ourfold faster turnover number, k cat (Table 2) . Whereast he catalytic efficiency of FL#62 in this non-native reaction is significantly lower than that of CYP102A1 for the hydroxylation of fatty acids (k cat /K M % 10 5 m À1 s À1 ) [18] ,i tf alls in the same range as those exhibited by P450s involved in druga nd hormonem etabolism (e.g.,P 4501B1/retinol, k cat /K M % 7 10 3 m À1 s
À1
). [19] For all the P450s, incubation with benzyla zide resultedi nas mall (< 5-10 %) butd etectable heme spin shift ( Figure S4 ), whichi si ndicative of the displacement of the axial water ligand on the heme by the bound substrate. Titration experiments revealed that FL#62 has ah igher bindinga ffinity for benzyla zide than wildtype CYP102A1 and CYP102A1(F87A) (dissociation constant, K D ,o f6 8mm vs. 93 and 84 mm,r espectively;T able2; Figure S4 ).
Another interesting result emerging from our substrate scope investigationsw ith FL#62 is the noticeable difference between the TON values associated with the synthesis of electron-deficient benzyl aldehydes (e.g., 5b;2 670 TONs)a nd those associatedw ith electron-rich ones (e.g., 4b;9 440). To elucidatet he basis of this trend, we extended the substrate binding experiments and Michaelis-Menten analyses to the FL#62-catalyzed oxidative deamination of p-nitrobenzyl azide (5a)a nd p-methoxybenzyl azide (4a). Whereas p-nitrobenzyl azide had weaker affinity for FL#62 than benzyl azide and pmethoxybenzyl azide (Table 2) , no significant differences were found among the kinetic parameters (K M , k cat )a nd catalytic efficiency (k cat /K M )o ft he enzyme for the transformation of these substrates, which suggested that other factors must be at the basis of the less efficient conversion of 5a compared to 4a and 1.
To furtherexaminethis aspect, we performed product inhibition experiments in which reaction mixtures containing FL#62 and 1, 4a,o r5a as the substrate were spiked with increasing concentrations (0-10 mm)o ft he corresponding aldehyde products.I nterestingly,t he addition of para-nitrobenzaldehyde (5b)s ignificantly reduced the conversion of 5a (Figure 4a) , which evidenced the occurrence of product inhibition. In contrast, no product inhibition was observed within the concentration range tested for both benzyl azide (1)( Figure S5 ) and para-methoxybenzyl azide (4b) ( Figure 4b) , thus explaining the greater yields observed in the presence of these substrates (Table 1) .
In conclusion, our results demonstrate that cytochrome P450s are promisingc atalysts for the synthesis of aromatic aldehydest hrough the oxidative deamination of alkyl azides. In particular, we established that the engineered CYP102A1 variant FL#62 represents as uperior biocatalyst forthis transformation relative to other heme-containing enzymes and the previously reportedM bc atalysts. In addition to excellent chemose- [a] Equilibrium dissociation constants( K D )w ere calculated from substrate-induced heme spin shift experiments( Figure S4 ).T he kinetic parameters( k cat , K M , k cat /K M )were calculated by nonlinear fitting of the V 0 vs. concentration curves (Figure3)t othe Michaelis-Mentenequation. ChemCatChem 2016 ChemCatChem , 8,2609 ChemCatChem -2613 www.chemcatchem.org lectivity and high catalytic activity (up to 11 300 TONs) across ab road range of alkyl azides, the enhanced reactivity of this P450 enabled extension of this transformation to the synthesis of ketones from secondary azides. These studies contributed valuablei nsighti nto the differential reactivitieso ft he hemoproteins and engineeredv ariants thereof in the context of non-native reactions, which is expected to aid the future development of biocatalysts for ag rowing number of synthetically useful transformationsnot found in nature.
